These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22583419)

  • 21. Methylenedioxy flavonoids: assessment of cytotoxic and anti-cancer potential in human leukemia cells.
    Orlikova B; Menezes JC; Ji S; Kamat SP; Cavaleiro JA; Diederich M
    Eur J Med Chem; 2014 Sep; 84():173-80. PubMed ID: 25016375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines.
    Cárdenas M; Marder M; Blank VC; Roguin LP
    Bioorg Med Chem; 2006 May; 14(9):2966-71. PubMed ID: 16412650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in studies on flavonoids of licorice].
    Xing GX; Li N; Wang T; Yao MY
    Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):593-7. PubMed ID: 15139098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships.
    Cao G; Sofic E; Prior RL
    Free Radic Biol Med; 1997; 22(5):749-60. PubMed ID: 9119242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary Phenolic Acids and Flavonoids as Potential Anti-Cancer Agents: Current State of the Art and Future Perspectives.
    Bonta RK
    Anticancer Agents Med Chem; 2020; 20(1):29-48. PubMed ID: 31648651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavonoids--food sources and health benefits.
    Kozłowska A; Szostak-Wegierek D
    Rocz Panstw Zakl Hig; 2014; 65(2):79-85. PubMed ID: 25272572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
    Pick A; Müller H; Mayer R; Haenisch B; Pajeva IK; Weigt M; Bönisch H; Müller CE; Wiese M
    Bioorg Med Chem; 2011 Mar; 19(6):2090-102. PubMed ID: 21354800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay.
    Wolfe KL; Liu RH
    J Agric Food Chem; 2008 Sep; 56(18):8404-11. PubMed ID: 18702468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review on Structural Trends and Chemotaxonomical Aspects of Pharmacologically Evaluated Flavonoids.
    Zouaoui S; Farman M; Semmar N
    Curr Top Med Chem; 2021; 21(7):628-648. PubMed ID: 33441067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural and Synthetic Flavonoids: Structure-Activity Relationship and Chemotherapeutic Potential for the Treatment of Leukemia.
    Menezes JC; Orlikova B; Morceau F; Diederich M
    Crit Rev Food Sci Nutr; 2016 Jul; 56 Suppl 1():S4-S28. PubMed ID: 26463658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and structure-activity relationship of novel semi-synthetic flavonoids as antiproliferative agents.
    Ragab FA; Yahya TA; El-Naa MM; Arafa RK
    Eur J Med Chem; 2014 Jul; 82():506-20. PubMed ID: 24937184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally-occurring dimers of flavonoids as anticarcinogens.
    Mercader AG; Pomilio AB
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1217-35. PubMed ID: 23796246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis and Biological Evaluation of Ligustrazine-Flavonoid Derivatives as Potential Anti-Tumor Agents.
    Wang H; Zhang W; Cheng Y; Zhang X; Xue N; Wu G; Chen M; Fang K; Guo W; Zhou F; Cui H; Ma T; Wang P; Lei H
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review on Pharmacological and Analytical Aspects of Naringenin.
    Patel K; Singh GK; Patel DK
    Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicities of some flavonoid analogues.
    Cushman M; Nagarathnam D
    J Nat Prod; 1991; 54(6):1656-60. PubMed ID: 1812215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs.
    Nakagawa-Goto K; Bastow KF; Wu JH; Tokuda H; Lee KH
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3016-9. PubMed ID: 15913998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets.
    Fardoun MM; Maaliki D; Halabi N; Iratni R; Bitto A; Baydoun E; Eid AH
    Clin Sci (Lond); 2020 Jun; 134(12):1403-1432. PubMed ID: 32556180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
    Saito Y; Mizokami A; Tsurimoto H; Izumi K; Goto M; Nakagawa-Goto K
    Eur J Med Chem; 2018 Sep; 157():1143-1152. PubMed ID: 30189396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structurally characterized gallium-chrysin complexes with anticancer potential.
    Halevas E; Mavroidi B; Antonoglou O; Hatzidimitriou A; Sagnou M; Pantazaki AA; Litsardakis G; Pelecanou M
    Dalton Trans; 2020 Feb; 49(8):2734-2746. PubMed ID: 32064490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.